After finishing at $2.65 in the prior trading day, Companhia Brasileira de Distribuicao (NYSE: CBD) closed at $2.64, down -0.38%. In other words, the price has decreased by -$0.0100 from its previous closing price. On the day, 1091688 shares were traded. CBD stock price reached its highest trading level at $2.6500 during the session, while it also had its lowest trading level at $2.5400.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Our goal is to gain a better understanding of CBD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.60. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.73.
Upgrades & Downgrades
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 0.32.
Stock Price History:
Over the past 52 weeks, CBD has reached a high of $5.50, while it has fallen to a 52-week low of $2.64. The 50-Day Moving Average of the stock is 3.3646, while the 200-Day Moving Average is calculated to be 3.5384.
The stock has traded on average 1.26M shares per day over the past 3-months and 1.24M shares per day over the last 10 days, according to various share statistics. A total of 269.00M shares are outstanding, with a floating share count of 159.44M. Insiders hold about 57.40% of the company’s shares, while institutions hold 5.80% stake in the company. Shares short for CBD as of Jan 30, 2023 were 1.52M with a Short Ratio of 2.01M, compared to 835.23k on Dec 29, 2022.
Dividends & Splits
In the trailing 12 months, CBD’s forward annual dividend rate was 1.92, compared to 0.07 this year. Against a Trailing Annual Dividend Yield of 72.53%, it implies a Forward Annual Dividend Yield of 2.14%. The stock’s 5-year Average Dividend Yield is 2.94.
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of $0.14 for the current quarter, with a high estimate of $0.14 and a low estimate of $0.14, while EPS last year was $0.53. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0.17 and -$0.22 for the fiscal current year, implying an average EPS of -$0.02. EPS for the following year is $0.33, with 2 analysts recommending between $0.41 and $0.26.
A total of 1 analysts have provided revenue estimates for CBD’s current fiscal year. The highest revenue estimate was $8.34B, while the lowest revenue estimate was $8.34B, resulting in an average revenue estimate of $8.34B. In the same quarter a year ago, actual revenue was $9.5B, down -12.30% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $8.77B in the next fiscal year. The high estimate is $8.77B and the low estimate is $8.77B. The average revenue growth estimate for next year is up 5.20% from the average revenue estimate for this year.